Secular trends in the incidence of hip and other osteoporotic fractures. by Cooper, C, Cole, Z, Holroyd, C, Earl, S, Harvey, N, Dennison, E, Melton, L, Cummings, SR, Kanis, J

“…We therefore conducted a review of studies worldwide, addressing secular trends in the incidence of hip and other fractures. …”

Social inequality and fractures-secular trends in the Danish population: a case-control study by Hansen, L, Judge, A, Javaid, M, Cooper, C, Vestergaard, P, Abrahamsen, B, Harvey, N

“…Married subjects had a significantly decreased odds ratio across all three fractures. However, no overall secular difference was observed regarding the influence of the markers of inequality.…”

Vitamin D and skeletal health in infancy and childhood. by Moon, R, Harvey, N, Davies, J, Cooper, C

“…Despite the suggestion from some studies of a secular increase in the incidence of rickets, this observation may be driven more by changes in population demographics than a true alteration to age, sex and ethnicity-specific incidence rates; indeed, rickets remains uncommon overall and is rarely seen in fair-skinned children. …”

Update on the epidemiology of Paget's disease of bone. by Cooper, C, Harvey, N, Dennison, E, van Staa, T

“…Recent studies of the secular trends in PDB suggest declining rates in both prevalence and severity at diagnosis. …”

Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study. by Klop, C, Welsing, P, Cooper, C, Harvey, N, Elders, P, Bijlsma, J, Leufkens, H, de Vries, F

“…Aims were therefore to examine secular trends in all-cause and cause-specific mortality post hip fracture and to compare this to the general population from 2000 to 2010. …”

Trends in oral anti-osteoporosis drug prescription in the United Kingdom between 1990 and 2012: Variation by age, sex, geographic location and ethnicity. by van der Velde, R, Wyers, C, Teesselink, E, Geusens, P, van den Bergh, J, de Vries, F, Cooper, C, Harvey, N, van Staa, T

“…</p> <h4>Conclusion</h4> <p>We have demonstrated marked secular changes in rates of anti-osteoporosis drug prescription over the last two decades. …”